Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2026 Jan 11;44(1):82.
doi: 10.1007/s00345-025-06179-y.

Real-world outcomes of bladder-sparing strategies for BCG-unresponsive non-muscle-invasive bladder cancer: a multicenter study

Affiliations

Real-world outcomes of bladder-sparing strategies for BCG-unresponsive non-muscle-invasive bladder cancer: a multicenter study

Pietro Scilipoti et al. World J Urol. .
No abstract available

Keywords: BCG-unresponsive; Bacillus Calmette-Guerin; Bladder-sparing therapy; EMDA; Gemcitabine and Docetaxel; Non-muscle invasive bladder cancer; Oncological outcomes; Survival.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of interest: The authors declare no competing interests. Ethical approval: This study was conducted in accordance with the Declaration of Helsinki. Informed consent was obtained from all individual participants included in the study.

References

    1. Gontero P, Birtle A, Capoun O et al (2024) European Association of Urology guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ)-a summary of the 2024 guidelines update. Eur Urol 86(6):531–549. https://doi.org/10.1016/j.eururo.2024.07.027 - DOI - PubMed
    1. Scilipoti P, Longoni M, de Angelis M et al (2025) Long-term oncological outcomes for patients with non-muscle-invasive bladder cancer treated with Bacillus Calmette-Guérin (BCG): a comparative analysis of adequate versus inadequate BCG treatment. Eur Urol Focus. https://doi.org/10.1016/j.euf.2025.04.033 - DOI - PubMed
    1. Longoni M, Scilipoti P, De Angelis M et al (2025) Contemporary outcomes in non-muscle-invasive bladder cancer: a large European multicentre study. BJU Int. https://doi.org/10.1111/bju.16780 - DOI - PubMed - PMC
    1. Scilipoti P, Longoni M, de Angelis M et al (2025) Outcomes of <scp>BCG</scp> vs upfront radical cystectomy for high‐risk non‐muscle‐invasive bladder cancer. BJU Int 136(1):47–54. https://doi.org/10.1111/bju.16675 - DOI - PubMed
    1. Pellegrino F, Leni R, Basile G et al (2024) Peri- and post-operative outcomes of robot-assisted radical cystectomy after the implementation of the EAU guidelines recommendations for collecting and reporting complications at a high-volume referral center. World J Urol 42(1):270. https://doi.org/10.1007/s00345-024-04970-x - DOI - PubMed

LinkOut - more resources